Form Bio Blog

Updates and perspectives from our industry experts, scientists and product leaders.

Category
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Understanding How Best to Allocate Resources When Training Large Language Models in Gene Therapy Development Programs
Cell and Gene Therapy

Understanding How Best to Allocate Resources When Training Large Language Models in Gene Therapy Development Programs

Nick Ketz, PhD

Nick Ketz, PhD

January 31, 2023

DeepMind researchers released a large language model (LLM) that uses fewer parameters yet achieves better performance. Read more to understand how this is relevant to your gene therapy programs.

How to leverage natural history studies to fill knowledge gaps in cell and gene therapy development
Cell and Gene Therapy

How to leverage natural history studies to fill knowledge gaps in cell and gene therapy development

Claire Aldridge, PhD

Claire Aldridge, PhD

January 17, 2023

Why are natural history studies important in cell and gene therapy development? Hear from our Chief Strategy Officer, Claire Aldridge, PhD on the importance of these studies and the need for effective data capture to make the most of them.

Single-Cell Techniques and Cell and Gene Therapy: How Integrating Multi-Omics Datasets is Driving Development Forward
Computational Life Sciences

Single-Cell Techniques and Cell and Gene Therapy: How Integrating Multi-Omics Datasets is Driving Development Forward

Jill Roughan, PhD

Jill Roughan, PhD

January 10, 2023

Single-cell analysis is uncovering unappreciated heterogeneity in biological systems. Learn how these techniques are changing how cell and gene therapies are developed.

Guest Post: What 2023 Holds for Cell and Gene Therapy
Cell and Gene Therapy

Guest Post: What 2023 Holds for Cell and Gene Therapy

ChatGPT

ChatGPT

December 7, 2022

With AI becoming not just inextricable but central for both science and software, we thought it fitting and worthwhile to utilize creative AI tools to see what 2023 might have in store for cell and gene therapy. Hence, our guest author is none other than OpenAI's ChatGPT.

How Next-Gen Editing Technologies are Transforming Cell and Gene Therapy Development
Computational Life Sciences

How Next-Gen Editing Technologies are Transforming Cell and Gene Therapy Development

Jill Roughan, PhD

Jill Roughan, PhD

February 7, 2023

Since their discovery, CRISPR-Cas systems have changed and evolved. Read about how base, prime, and RNA editing are driving new therapeutic applications.

How Top Biotechs Manufacture the Safest AAV Vectors for Gene Therapies
Cell and Gene Therapy

How Top Biotechs Manufacture the Safest AAV Vectors for Gene Therapies

Jill Roughan, PhD

Jill Roughan, PhD

February 1, 2023

As gene therapy becomes more prevalent, so too do the challenges associated with ensuring its safety. Learn how to manufacture the purest and most potent AAV based gene therapy.

The Biologist’s Introduction to Computational Life Sciences
Computational Life Sciences

The Biologist’s Introduction to Computational Life Sciences

Jill Roughan, PhD

Jill Roughan, PhD

December 27, 2022

Read here for an introduction to the emerging field of computational life sciences and its broad impact and applications in solving challenging research and clinical problems.

How Computational Life Sciences Enables Metagenomics Studies
Computational Life Sciences

How Computational Life Sciences Enables Metagenomics Studies

Jill Roughan, PhD

Jill Roughan, PhD

December 13, 2022

Metagenomics studies and sophisticated computational tools advance disciplines from basic research to healthcare. Find out more in our blog.

Breakdown of the History and Recent Rapid Development of Biomanufacturing
Computational Life Sciences

Breakdown of the History and Recent Rapid Development of Biomanufacturing

Alexander Titus, PhD

Alexander Titus, PhD

December 9, 2022

The future of biomanufacturing is bright. Read here to learn about history and recent developments in this emerging domestic industry.

Applying Data Visualization Tools to Advance Cell and Gene Therapy Research
Cell and Gene Therapy

Applying Data Visualization Tools to Advance Cell and Gene Therapy Research

Jill Roughan, PhD

Jill Roughan, PhD

November 29, 2022

The ability to interpret data is crucial to advancing cell and gene therapy research. Read on to hear how researchers are presenting data in an accessible way.

How Top Biotechs Use Deep Learning to Drive Development of Cell and Gene Therapy
Cell and Gene Therapy

How Top Biotechs Use Deep Learning to Drive Development of Cell and Gene Therapy

Jill Roughan, PhD

Jill Roughan, PhD

November 15, 2022

The power of deep learning for discovering and developing cell and gene therapies is undeniable. Learn how to implement it with these 10 actionable tips.

Sequencing and Computational Life Sciences: Making Sense of Big Genomic Data
Computational Life Sciences

Sequencing and Computational Life Sciences: Making Sense of Big Genomic Data

Jill Roughan, PhD

Jill Roughan, PhD

November 8, 2022

Sequencing technologies have seen many remarkable innovations over the last decade and shows no signs of slowing down. Read here for emerging trends.

Form Bio Resources

How Next-Gen Editing Technologies are Transforming Cell and Gene Therapy Development
Computational Life Sciences

How Next-Gen Editing Technologies are Transforming Cell and Gene Therapy Development

Jill Roughan, PhD

Jill Roughan, PhD

February 7, 2023

Since their discovery, CRISPR-Cas systems have changed and evolved. Read about how base, prime, and RNA editing are driving new therapeutic applications.

How Top Biotechs Manufacture the Safest AAV Vectors for Gene Therapies
Cell and Gene Therapy

How Top Biotechs Manufacture the Safest AAV Vectors for Gene Therapies

Jill Roughan, PhD

Jill Roughan, PhD

February 1, 2023

As gene therapy becomes more prevalent, so too do the challenges associated with ensuring its safety. Learn how to manufacture the purest and most potent AAV based gene therapy.

Understanding How Best to Allocate Resources When Training Large Language Models in Gene Therapy Development Programs
Cell and Gene Therapy

Understanding How Best to Allocate Resources When Training Large Language Models in Gene Therapy Development Programs

Nick Ketz, PhD

Nick Ketz, PhD

January 31, 2023

DeepMind researchers released a large language model (LLM) that uses fewer parameters yet achieves better performance. Read more to understand how this is relevant to your gene therapy programs.

Board of Directors

Doe

Johnnn

Doe

,

Ph.D.

CEO
Doe

Johnn

Doe

,

Ph.D.

CEO
Doe

John

Doe

,

Ph.D.

CEO
Doe

Johnnn

Doe

,

Ph.D.

CEO

Form your future breakthroughs

See how Form can empower you

Get a Demo

Get informed

Visit our Resource Center
Subscribe to the Newsletter
Contact Sales

Form Bio Resources

Computational Life Sciences

How Next-Gen Editing Technologies are Transforming Cell and Gene Therapy Development

Since their discovery, CRISPR-Cas systems have changed and evolved. Read about how base, prime, and RNA editing are driving new therapeutic applications.

Cell and Gene Therapy

How Top Biotechs Manufacture the Safest AAV Vectors for Gene Therapies

As gene therapy becomes more prevalent, so too do the challenges associated with ensuring its safety. Learn how to manufacture the purest and most potent AAV based gene therapy.

Cell and Gene Therapy

Understanding How Best to Allocate Resources When Training Large Language Models in Gene Therapy Development Programs

DeepMind researchers released a large language model (LLM) that uses fewer parameters yet achieves better performance. Read more to understand how this is relevant to your gene therapy programs.